TotalMarketCap

Aytu Biopharma

AYTUNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$19.889 M

$1.83 -4.69%

Close of 6 Nov 2026

As of 6 Nov 2026, Aytu Biopharma (AYTU) has a market capitalization of $19.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$66.4M

#2627 by revenue

Earnings

-$13.6M

Loss-making

Shares outstanding

10,866,708

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #383Atossa TherapeuticsATOS$20.1M
  2. #384TherapeuticsMDTXMD$20.0M
  3. #385Aytu BiopharmaAYTU$19.9M
  4. #386Cocrystal PharmaCOCP$19.5M
  5. #387Quoin PharmaceuticalsQNRX$18.5M

What if Aytu Biopharma were worth as much as…

Open the what-if tool →

Gold $28.2T

$2,598,117

Per share 1,419,736× higher

Bitcoin $1.53T

$140,579.57

Per share 76,819× higher

Apple $5.02T

$461,509.62

Per share 252,191× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Aytu Biopharma are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.